Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for GBLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2024 407.07M
September 30, 2024 407.07M
June 30, 2024 407.07M
March 31, 2024 406.07M
December 31, 2023 406.07M
September 30, 2023 402.74M
June 30, 2023 381.87M
March 31, 2023 381.87M
December 31, 2022 379.21M
September 30, 2022 378.21M
June 30, 2022 329.21M
March 31, 2022 325.04M
December 31, 2021 317.44M
September 30, 2021 317.43M
June 30, 2021 317.43M
March 31, 2021 315.34M
December 31, 2020 283.82M
September 30, 2020 280.53M
June 30, 2020 280.53M
March 31, 2020 275.54M
December 31, 2019 270.55M
September 30, 2019 255.34M
June 30, 2019 246.85M
March 31, 2019 240.63M
December 31, 2018 228.07M
Date Value
September 30, 2018 221.76M
June 30, 2018 186.05M
March 31, 2018 168.62M
December 31, 2017 131.25M
September 30, 2017 127.93M
June 30, 2017 127.67M
March 31, 2017 124.41M
December 31, 2016 92.84M
September 30, 2016 77.77M
June 30, 2016 57.97M
March 31, 2016 47.34M
December 31, 2015 45.91M
September 30, 2015 46.31M
June 30, 2015 45.32M
March 31, 2015 35.97M
December 31, 2014 34.90M
September 30, 2014 34.36M
June 30, 2014 32.47M
March 31, 2014 7.269M
December 31, 2013 0.8501M
September 30, 2013 0.8501M
June 30, 2013 0.8501M
March 31, 2013 0.8501M
December 31, 2012 0.8501M
September 30, 2012 0.8501M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. 13.79M
CNBX Pharmaceuticals, Inc. 1.476B
Arvinas, Inc. 65.30M
Fulcrum Therapeutics, Inc. 76.29M
Definium Therapeutics, Inc. 134.37M